New Cancer Gene Discovered

	Tweet

Researchers at the OU Cancer Institute have identified a new gene that causes cancer. The ground-breaking research appears Monday in Nature’s cancer journal Oncogene.

The gene and its protein, both called RBM3, are vital for cell division in normal cells. In cancers, low oxygen levels in the tumors cause the amount of this protein to go up dramatically. This causes cancer cells to divide uncontrollably, leading to increased tumor formation.

Researchers used new powerful technology to genetically “silence” the protein and reduce the level of RBM3 in cancerous cells. The approach stopped cancer from growing and led to cell death. The new technique has been tested successfully on several types of cancers – breast, pancreas, colon, lung, ovarian and prostate.

“We are excited about this discovery because most cancers are thought to come from mutations in genes, and our studies, for the first time, have shown that too much of this type of protein actually causes normal cells to turn into cancer cells,” said Shrikant Anant, Ph.D., a cancer biologist at the OU Cancer Institute and principal investigator on the project.

Anant said they found RBM3 protein in every stage of many cancers, and the amount of protein increased as the cancer grew. The protein helped the cancer grow faster, avoid cell death and was part of the process that formed new blood vessels to feed the tumor.

“This process, called angiogenesis, is essential for tumor growth and suggests that targeting RBM3 may be an extremely powerful tool against many and perhaps all solid tumors,” Anant said.

A quarter of the funding for the cancer research comes from an $800,000 grant from the National Institutes of Health with remaining funds from the University of Oklahoma College of Medicine. The next step for Anant, Dr. Courtney Houchen and their research team at the OU Health Sciences Center is to develop agents that block the protein function in a variety of cancers. Researchers expect to start clinical trials at OU in about five years.

The University of Oklahoma Health Sciences Center
1100 N. Lindsay, Oklahoma City, OK 73104
(405) 271-4000

RELATED STORIES:
Childhood Leukemia Survivors Struggle With Long-Term Comorbidities   Life Lessons on Cancer Risk for Children Whose Parent Has Genetic Mutation   Deleted Genes Help Predict Outcome in a Children’s Cancer   In the test tube, teams reconstruct a cancer cell’s beginning   Study Predicts Dramatic Growth in Cancer Rates Among U.S. Elderly, Minorities   Multikine treatment increases survival in cancer patients   Amgen, Abgenix antibody curbs colon cancer   New Synthetic Form of Protein Holds Promise to Stop Cancer Spread   New imaging technique accurately finds cancer cells, fast   Men with BRCA2 gene mutation have higher cancer risk   Researchers Identify Cancer Preventive Properties in Common Vitamin Supplement   Nanocenter Offers Promising Non-Invasive Cancer Treatment   Scientists detect cancer genes with new algorithm   UK cancer map shows way to save 17,000 lives a year   Report outlines successes, challenges in cancer prevention efforts   Unlocking the body’s defenses against cancer   Fruit research yields way to curb cancer   Combining Two Peptide Inhibitors Might Block Tumor Growth   CT scans: Too much of a good thing can be risky   Drug Could Effectively Treat, Prevent the Spread of Breast Cancer   How cancer cells can escape normal growth controls   University of the Basque Country team develop nano-hydrogels capable of detecting cancer cells

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]